The Cancer Community at Illinois (CC@IL) is pleased to announce it has named Rohit Bhargava its director for a three-year term.
Bhargava, who has served as the faculty coordinator for the Cancer Community at Illinois for the past four years and has exceptional research productivity and experience in leading the CC@IL, will spearhead efforts to unite researchers working to find better ways to prevent, detect, diagnose and treat cancer.
The CC@IL provides resources for cancer-related activities across the campus, nucleates new programs related to cancer research, and fosters connections with clinical partners.
Bhargava is a professor and Abel Bliss Scholar in the Department of Bioengineering. He is deeply involved in cancer research, with extensive grant funding for numerous projects. One example is a project aimed at developing innovative cancer imaging techniques to determine the risk of lethal prostate cancer upon initial diagnosis. This project, “3D Prostate Histochemometry to Predict Disease Recurrence,” has been awarded more than $1.6 million over four years by the National Cancer Institute of the National Institutes of Health.
Bhargava received his Ph.D. from Case Western Reserve University and his undergraduate degree from the Indian Institute of Technology, New Delhi. He has a fulltime faculty affiliation with the Beckman Institute for Advanced Science and Technology, is a research affiliate at the Mills Breast Cancer Institute at Carle Foundation Hospital, and has played a central role in the Interdisciplinary Health Sciences Initiative’s (IHSI) support of cancer-related research. His fields of professional interest include infrared spectroscopic imaging, cancer pathology, probes for molecular imaging, polymer structure, and numerical methods for image processing.
The CC@IL is supported by IHSI, the College of Engineering, the Department of Bioengineering, and the Beckman Institute for Advanced Science and Technology.
Cancer Community at Illinois website: